Ladenburg Thalmann Financial Services’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,435
| Closed | -$165K | – | 5684 |
|
|
2019
Q3 | $165K | Sell |
2,435
-866
| -26% | -$58.7K | ﹤0.01% | 2609 |
|
|
2019
Q2 | $192K | Buy |
3,301
+372
| +13% | +$21.6K | ﹤0.01% | 2505 |
|
|
2019
Q1 | $206K | Buy |
2,929
+327
| +13% | +$23K | ﹤0.01% | 2373 |
|
|
2018
Q4 | $167K | Buy |
2,602
+753
| +41% | +$48.3K | ﹤0.01% | 2367 |
|
|
2018
Q3 | $130K | Buy |
1,849
+430
| +30% | +$30.2K | ﹤0.01% | 2638 |
|
|
2018
Q2 | $45K | Hold |
1,419
| – | – | ﹤0.01% | 3334 |
|
|
2018
Q1 | $45K | Sell |
1,419
-429
| -23% | -$13.6K | ﹤0.01% | 3334 |
|
|
2017
Q4 | $64K | Buy |
1,848
+444
| +32% | +$15.4K | ﹤0.01% | 3063 |
|
|
2017
Q3 | $45K | Sell |
1,404
-146
| -9% | -$4.68K | ﹤0.01% | 3163 |
|
|
2017
Q2 | $51K | Buy |
1,550
+64
| +4% | +$2.11K | ﹤0.01% | 3018 |
|
|
2017
Q1 | $47K | Buy |
1,486
+33
| +2% | +$1.04K | ﹤0.01% | 2967 |
|
|
2016
Q4 | $43K | Buy |
1,453
+236
| +19% | +$6.98K | ﹤0.01% | 2961 |
|
|
2016
Q3 | $35K | Sell |
1,217
-136
| -10% | -$3.91K | ﹤0.01% | 3052 |
|
|
2016
Q2 | $35K | Buy |
1,353
+178
| +15% | +$4.61K | ﹤0.01% | 2962 |
|
|
2016
Q1 | $29K | Buy |
1,175
+2
| +0.2% | +$49 | ﹤0.01% | 3001 |
|
|
2015
Q4 | $41K | Sell |
1,173
-185
| -14% | -$6.47K | ﹤0.01% | 2717 |
|
|
2015
Q3 | $29K | Buy |
1,358
+15
| +1% | +$320 | ﹤0.01% | 2856 |
|
|
2015
Q2 | $37K | Buy |
1,343
+18
| +1% | +$496 | ﹤0.01% | 2804 |
|
|
2015
Q1 | $40K | Buy |
1,325
+19
| +1% | +$574 | ﹤0.01% | 2733 |
|
|
2014
Q4 | $42K | Hold |
1,306
| – | – | ﹤0.01% | 2484 |
|
|
2014
Q3 | $37K | Buy |
1,306
+705
| +117% | +$20K | ﹤0.01% | 2236 |
|
|
2014
Q2 | $16K | Buy |
601
+301
| +100% | +$8.01K | ﹤0.01% | 2831 |
|
|
2014
Q1 | $8K | Sell |
300
-434
| -59% | -$11.6K | ﹤0.01% | 3085 |
|
|
2013
Q4 | $21K | Hold |
734
| – | – | ﹤0.01% | 2517 |
|
|
2013
Q3 | $22K | Hold |
734
| – | – | ﹤0.01% | 2392 |
|
|
2013
Q2 | $23K | Buy |
+734
| New | +$23K | ﹤0.01% | 2261 |
|